Topic

Peptides & GLP-1

The fastest-moving and least regulated corner of wellness. GLP-1s, NAD+, BPC-157 and the rest — separated into what has human trials, what needs a prescription, and what is a grey-market vial with a marketing budget.

Our lens: What is prescription, what is research-grade, and what is being sold to you.

Learn

Peptides & GLP-1

GLP-1 Drugs, Explained Without the Hype

Semaglutide and tirzepatide are the most effective weight-loss drugs ever brought to market. They are also prescription medicines with real side effects and a large grey market growing around them.

Peptides & GLP-1

GLP-1s and Muscle Loss: What to Do About It

A large share of the weight lost on a GLP-1 is lean mass. Two interventions blunt it, and both are things you would want to be doing anyway.

Peptides & GLP-1

NAD+, NMN and NR: What the Human Evidence Actually Shows

The mechanism is real and genuinely interesting. The human outcome data is thinner than the marketing, and one of these was pulled from the US supplement market.

Peptides & GLP-1

BPC-157: What We Know, and Why It Is Not a Supplement

A peptide with encouraging animal data, almost no human trials, and a specific regulatory status that most sellers do not mention.

Guides

Peptides & GLP-1

Peptide Safety and Sourcing: A Buyer's Checklist

The compound is rarely the biggest risk. Where it came from usually is.